Cargando…
Diabetes and the Course of Febrile Urinary Tract Infection
Autores principales: | van der Starre, Willize E., Borgdorff, Hanneke, Vollaard, Albert M., Delfos, Nathalie M., van ’t Wout, Jan W., Spelt, Ida C., Blom, Jeanet W., Leyten, Eliane M.S., Koster, Ted, Ablij, Hans C., van Dissel, Jaap T., van Nieuwkoop, Cees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836111/ https://www.ncbi.nlm.nih.gov/pubmed/24265368 http://dx.doi.org/10.2337/dc13-0903 |
Ejemplares similares
-
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule
por: Stalenhoef, Janneke E., et al.
Publicado: (2017) -
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
por: van Nieuwkoop, Cees, et al.
Publicado: (2017) -
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)
por: van Nieuwkoop, Cees, et al.
Publicado: (2009) -
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019) -
Treatment Duration of Febrile Urinary Tract Infections
por: van der Starre, Willize E., et al.
Publicado: (2011)